Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Inwardly Rectifying Potassium Channels in the Regulation of Vascular Tone

Volume:4   Issue: 4
Pp: 281-289
Sophocles Chrissobolis and Christopher G. Sobey
DOI: 10.2174/1389450033491046

Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy

Volume:4   Issue: 4
Pp: 291-296
E. Fonsatti, M. Altomonte, P. Arslan and M. Maio
DOI: 10.2174/1389450033491073

Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy

Volume:4   Issue: 4
Pp: 297-304
Matteo Marroni, Nicola Marchi, Luca Cucullo, N. Joan Abbott, Kathy Signorelli and Damir Janigro
DOI: 10.2174/1389450033491109

The Molecular Targets of Antitumor 2-deoxycytidine Analogues

Volume:4   Issue: 4
Pp: 305-313
Tohru Obata, Yoshio Endo, Daigo Murata, Kazuki Sakamoto and Takuma Sasaki
DOI: 10.2174/1389450033491037

Anticoagulant Therapy for Acute Lung Injury or Pneumonia

Volume:4   Issue: 4
Pp: 315-321
Marcus J. Schultz, Marcel Levi and Tom van der Poll
DOI: 10.2174/1389450033491064

Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate

Volume:4   Issue: 4
Pp: 323-338
F. Chimienti, M. Aouffen, A. Favier and M. Seve
DOI: 10.2174/1389450033491082

Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases

Volume:4   Issue: 4
Pp: 339-346
Naruya Tomita, Haruhito Azuma, Yasufumi Kaneda, Toshio Ogihara and Ryuichi Morishita
DOI: 10.2174/1389450033491055

Update on Tandem Pore (2P) Domain K+ Channels

Volume:4   Issue: 4
Pp: 347-351
C. Spencer Yost
DOI: 10.2174/1389450033491091